Connect with us

China

GOP Reps. Ask WHO’s Dr. Tedros To Testify, Accuse Him Of ‘Shielding China’

Published

on

WHO Director tedros adhanom ghebreyesus

Republican lawmakers on the House Subcommittee on the Coronavirus Crisis along with Oversight Committee Ranking member James Comer, R-KY, requested Wednesday that World Health Organization Director-General Tedros Adhanom Ghebreyesus testify before the committee and answer to “revelations that WHO provided false information to Congress about China’s actions in the pandemic.”

The WHO previously reported learning of a cluster of pneumonia cases from China in late December in response to the Committee’s request for information in April. That story has since changed. Last week, the WHO quietly updated their timeline on the discovery of the novel coronavirus, saying they first learned of the virus from a U.S. website, first reported by The Washington Free Beacon.

“This revelation demands your complete and forthright response to the Committee’s previous request and sworn testimony before the Select Subcommittee on the Coronavirus Crisis (the Select Subcommittee). Until you appear under oath, America and the world will not know the origins of this crisis,” the lawmakers wrote.

“By refusing to disclose the truth, you have shielded China from accountability,” the Republicans added. “Your public statements regarding the initial outbreak coupled with the WHO website and your June 15 letter to this Committee demonstrate an endorsement of the CCP propaganda efforts to cover up the origins of this virus and mislead the world.”

President Donald Trump has been moving to withdraw the U.S. from the WHO, saying the organization and its leadership are “China-centric.” This week, he made it official in a notice to Congress and the United Nations.

Republicans on the House Oversight Committee first wrote to Dr. Tedros in April about his organization’s mishandling of the COVID-19 pandemic and raised concerns over its alleged “improper relationship with the Chinese Communist Party.”

Their calls for transparency from the WHO chief were ignored by Democrats on the Committee who refused requests in late April and in May to investigate the WHO.

The WHO responded to the April letter on June 15, and its response, the GOP members say, was “wholly incomplete and contained at least the one false statement.”

The WHO earlier praised China’s response to the pandemic and lauded the Chinese government’s efforts to contain the virus. The organization also spread misinformation that the virus couldn’t be spread from person-to-person, ignoring early warnings from Taiwan.

You may like

Continue Reading

China

China Says It’s Ready for Monkeypox and the West Isn’t

Published

on

China

As the Western press is becoming more and more concerned with monkeypox outbreaks, a recent bombshell report shows that Wuhan Institute of Virology (WIV) in China manipulated monkeypox to be more contagious in humans. This follows more evidence that the WIV had been experimenting with bat coronaviruses to increasingly infect humans.

But rather than agree to an honest investigation into the WIV and its role in spreading contagion around the world, China is once again trying to sell us an alternative reality. According to Chinese state-run media, it is China that is once again poised to be humanity’s savior and darling when it comes to fighting monkeypox, much like COVID-19. Not only that, but CCP press reporting shows evidence of China having an eerily well advanced infrastructure and gameplan to fight monkeypox. The West in contrast is not prepared, according to China.

Claim #1: China has the Wisdom to Fight Monkeypox

First, Chinese state-run media portray China as in a good position to combat monkeypox due to wisdom gleaned from combating COVID-19 and smallpox. One Global Times article noted that “[i]n the very early stage of the COVID-19 pandemic, China has taken the measures of ‘early identification, reporting, isolation, diagnosis and treatment.’ Under such guidance, China has become one of the most successful countries in the COVID fight.” Another Global Times article cites a World Health Organization official as stating that “China’s COVID-19 control measures in place and largely reduced international arrivals minimize the risks of contagion in China.” A third Global Times article, citing “experts,” claims that “China’s successful experience in eliminating smallpox would also help the country act if monkeypox enters China’s borders…”

Claim #2: Chinese Healthcare Infrastructure Is Well Prepared to Deal with Monkeypox

China is well ahead of the game in dealing with monkeypox, according to Chinese state-run media. Chinese experts “suggest preparation of testing and treatment capacities in advance” to proactively combat monkeypox, according to Global Times. And “drug research should start early so that China can still control [monkeypox] should it assume pandemic proportions,” according to China Daily.

China is apparently quite far along in this “preparation” and “research.”

There are “several” Chinese manufacturers that have already made monkeypox nucleic acid test kits, and that these “can be quickly put into mass production and on the domestic market once approved by the government,” according to a second Global Times article.  This article also states that Chinese manufacturer Liferiver Bio-Tech has a nucleic acid test that has already been ordered in China and abroad.

This same article also states that vaccine development faces “no technological problems” and a vaccine can be produced in China in a year if China’s drug administration administers “a rapid special review.” China’s CDC also has already stockpiled “millions” of doses of smallpox vaccine, produced “an emergency response technical plan on monkeypox, stocked monkeypox detection reagents, and conducted training on monkeypox nucleic acid PCR testing for provincial and municipal CDC professionals.”

Mirroring its earlier “mask diplomacy” for COVID-19, it looks like China is beginning to export its healthcare to the world to help combat monkeypox. China’s Sansure Biotech is ready to register its nucleic acid test kit for monkeypox abroad, according to Global Times. And Jiangsu Bioperfectus Technologies has already has its Monkeypox Virus Real Time PCR Kits in the international market, according to Global Times.

Claim #3: The West is Ill-Equipped to Handle Monkeypox

On the other hand, Chinese media portrays the West as ill-equipped to handle monkeypox. For example, according to one Global Times editorial, “[t]he COVID pandemic that killed more than 1 million people in the US has given a tragic lesson to the US and the West, but it still remains to be seen to what extent the US and the West learned from it.” The West’s “conspiracy theories” and “panic” contributed to the “Western countries’ poor response to COVID-19.” That CCP editorial also pontificates that “[i]t is hoped that Western countries hit by monkeypox can do a good job in responding to the outbreak. They should not misjudge the virus with outdated perceptions…”

Claim #4: Current Monkeypox spread originated from outside China

Chinese media avoids the possibility that this current monkeypox outbreak could have originated in China. One Global Times article claims that there have been no cases of monkeypox reported in China, and that China faces a threat from monkeypox due to the cases being “outside known epidemic areas of Africa.” The fact that many countries have now lifted bans against international travel is the culprit for increased risk of monkeypox transmission, according to anonymous source within the Chinese CDC as mentioned in that same article. Another Global Times article stated that China could quarantine inbound international travellers “if necessary.”

The CCP propaganda machine is at it again.  Much like it tries to portray itself as a leader in fighting COVID-19, China is beginning to run a similar propaganda campaign for monkeypox. China is using COVID-19, and increasingly now monkeypox, as vehicles to curry favor and deflect responsibility for spreading contagion around the world, and to grow markets for healthcare technology and supplies.

You may like

Continue Reading
Advertisement

Trending Now

Advertisement

Trending

Proudly Made In America | © 2022 M3 Media Management, LLC